A Phase I Study of Single Subcutaneous Dose of SHR-1894 in Healthy Subjects

Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2026
The Phase I clinical study aims to evaluate the safety, tolerability, pharmacokinetics and pharmacodynamics of SHR-1894 in healthy subjects.
Epistemonikos ID: 7411a534bd3fc9d0297f82257b5094ee5f337400
First added on: Feb 18, 2026